FSMEX vs. FBDIX
FSMEX (Fidelity Select Medical Technology and Devices Portfolio) and FBDIX (Franklin Biotechnology Discovery Fund) are both Health & Biotech Equities funds. Over the past 10 years, FSMEX returned 9.47%/yr vs 9.81%/yr for FBDIX. A 0.68 correlation means they provide meaningful diversification when combined. FSMEX charges 0.68%/yr vs 1.06%/yr for FBDIX.
Performance
FSMEX vs. FBDIX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FSMEX achieves a -17.61% return, which is significantly lower than FBDIX's 0.59% return. Both investments have delivered pretty close results over the past 10 years, with FSMEX having a 9.47% annualized return and FBDIX not far ahead at 9.81%.
FSMEX
- 1D
- -1.64%
- 1M
- 2.05%
- YTD
- -17.61%
- 6M
- -18.69%
- 1Y
- -11.90%
- 3Y*
- 0.79%
- 5Y*
- -0.96%
- 10Y*
- 9.47%
FBDIX
- 1D
- -4.72%
- 1M
- -5.53%
- YTD
- 0.59%
- 6M
- 1.88%
- 1Y
- 59.54%
- 3Y*
- 26.59%
- 5Y*
- 8.23%
- 10Y*
- 9.81%
FSMEX vs. FBDIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FSMEX Fidelity Select Medical Technology and Devices Portfolio | -17.61% | 8.13% | 18.37% | 0.62% | -24.84% | 24.56% | 30.18% | 29.58% | 15.98% | 26.66% |
FBDIX Franklin Biotechnology Discovery Fund | 0.59% | 52.68% | 15.37% | 18.40% | -12.65% | -27.58% | 29.85% | 49.11% | -15.77% | 18.83% |
Correlation
The correlation between FSMEX and FBDIX is 0.47, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.47 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.54 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.61 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.63 |
Correlation (All Time) Calculated using the full available price history since Apr 29, 1998 | 0.68 |
Over the past year, the correlation between FSMEX and FBDIX has dropped to 0.47 - well below their long-term average of 0.68, suggesting their price drivers have been diverging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FSMEX vs. FBDIX — Risk / Return Rank
FSMEX
FBDIX
FSMEX vs. FBDIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Medical Technology and Devices Portfolio (FSMEX) and Franklin Biotechnology Discovery Fund (FBDIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FSMEX | FBDIX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.65 | 2.69 | -3.34 |
Sortino ratioReturn per unit of downside risk | -0.82 | 3.54 | -4.36 |
Omega ratioGain probability vs. loss probability | 0.91 | 1.44 | -0.53 |
Calmar ratioReturn relative to maximum drawdown | -0.45 | 6.76 | -7.21 |
Martin ratioReturn relative to average drawdown | -1.08 | 23.11 | -24.20 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| FSMEX | FBDIX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.65 | 2.69 | -3.34 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | 0.32 | -0.37 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.46 | 0.37 | +0.08 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.64 | 0.40 | +0.24 |
Drawdowns
FSMEX vs. FBDIX - Drawdown Comparison
The maximum FSMEX drawdown since its inception was -40.34%, smaller than the maximum FBDIX drawdown of -71.44%. Use the drawdown chart below to compare losses from any high point for FSMEX and FBDIX.
Loading charts...
Drawdown Indicators
| FSMEX | FBDIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.34% | -71.44% | +31.10% |
Max Drawdown (1Y)Largest decline over 1 year | -26.28% | -9.18% | -17.10% |
Max Drawdown (3Y)Largest decline over 3 years | -26.28% | -24.22% | -2.06% |
Max Drawdown (5Y)Largest decline over 5 years | -40.34% | -46.83% | +6.49% |
Max Drawdown (10Y)Largest decline over 10 years | -40.34% | -53.67% | +13.33% |
Current DrawdownCurrent decline from peak | -22.84% | -9.18% | -13.66% |
Average DrawdownAverage peak-to-trough decline | -7.75% | -28.74% | +20.99% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.81% | 2.68% | +8.13% |
Volatility
FSMEX vs. FBDIX - Volatility Comparison
The current volatility for Fidelity Select Medical Technology and Devices Portfolio (FSMEX) is 7.26%, while Franklin Biotechnology Discovery Fund (FBDIX) has a volatility of 8.88%. This indicates that FSMEX experiences smaller price fluctuations and is considered to be less risky than FBDIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FSMEX | FBDIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.26% | 8.88% | -1.62% |
Volatility (6M)Calculated over the trailing 6-month period | 14.54% | 17.92% | -3.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.08% | 23.10% | -5.02% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.01% | 25.75% | -4.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.76% | 26.33% | -5.57% |
FSMEX vs. FBDIX - Expense Ratio Comparison
FSMEX has a 0.68% expense ratio, which is lower than FBDIX's 1.06% expense ratio.
Dividends
FSMEX vs. FBDIX - Dividend Comparison
FSMEX's dividend yield for the trailing twelve months is around 22.03%, more than FBDIX's 10.75% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBDIX Franklin Biotechnology Discovery Fund | 10.75% | 10.81% | 19.53% | 0.00% | 0.13% | 0.98% | 14.50% | 18.77% | 3.72% | 2.39% | 4.57% | 8.42% |
FSMEX Fidelity Select Medical Technology and Devices Portfolio | 22.03% | 10.53% | 17.04% | 0.00% | 1.80% | 8.12% | 6.65% | 1.77% | 7.47% | 6.26% | 5.84% | 16.35% |
Frequently Asked Questions
FSMEX and FBDIX have a correlation of 0.47, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FBDIX has higher volatility (8.88%) compared to FSMEX (7.26%). In terms of maximum drawdown, FSMEX dropped -40.34% vs FBDIX's -71.44%.
FBDIX currently has the higher Sharpe Ratio (2.69 vs -0.65), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FSMEX and FBDIX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer